1. Home
  2. KVAC vs CYBN Comparison

KVAC vs CYBN Comparison

Compare KVAC & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVAC
  • CYBN
  • Stock Information
  • Founded
  • KVAC 2021
  • CYBN 2019
  • Country
  • KVAC United States
  • CYBN Canada
  • Employees
  • KVAC N/A
  • CYBN N/A
  • Industry
  • KVAC
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • KVAC
  • CYBN Health Care
  • Exchange
  • KVAC Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • KVAC 212.1M
  • CYBN 177.9M
  • IPO Year
  • KVAC 2023
  • CYBN N/A
  • Fundamental
  • Price
  • KVAC $11.13
  • CYBN $9.09
  • Analyst Decision
  • KVAC
  • CYBN Strong Buy
  • Analyst Count
  • KVAC 0
  • CYBN 3
  • Target Price
  • KVAC N/A
  • CYBN $111.50
  • AVG Volume (30 Days)
  • KVAC 7.5K
  • CYBN 340.0K
  • Earning Date
  • KVAC 01-01-0001
  • CYBN 02-28-2025
  • Dividend Yield
  • KVAC N/A
  • CYBN N/A
  • EPS Growth
  • KVAC N/A
  • CYBN N/A
  • EPS
  • KVAC 0.43
  • CYBN N/A
  • Revenue
  • KVAC N/A
  • CYBN N/A
  • Revenue This Year
  • KVAC N/A
  • CYBN N/A
  • Revenue Next Year
  • KVAC N/A
  • CYBN N/A
  • P/E Ratio
  • KVAC $25.80
  • CYBN N/A
  • Revenue Growth
  • KVAC N/A
  • CYBN N/A
  • 52 Week Low
  • KVAC $10.38
  • CYBN $6.50
  • 52 Week High
  • KVAC $11.14
  • CYBN $19.84
  • Technical
  • Relative Strength Index (RSI)
  • KVAC 69.43
  • CYBN 41.61
  • Support Level
  • KVAC $11.10
  • CYBN $9.08
  • Resistance Level
  • KVAC $11.14
  • CYBN $10.59
  • Average True Range (ATR)
  • KVAC 0.00
  • CYBN 0.67
  • MACD
  • KVAC -0.00
  • CYBN -0.04
  • Stochastic Oscillator
  • KVAC 80.00
  • CYBN 13.76

About KVAC Keen Vision Acquisition Corporation

Keen Vision Acquisition Corp is a blank check company.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

Share on Social Networks: